Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PulsenmorePLSM -6.70%25 Days Payable is 99.24 as of Dec. 2025, which is 55% below its 10-year median of 218.47. GuruFocus rates PLSM with a GF Score™ of 25/100 and a GF Value™ of $8.16 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 796 Medical Devices & Instruments companies, Pulsenmore ranks better than 72.49% on this metric.
Pulsenmore's average Accounts Payable for the
six
months ended in Dec. 2025 was $0.68 Mil. Pulsenmore's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $1.26 Mil.
Hence, Pulsenmore's Days Payable for the
six
months ended in Dec. 2025 was 99.24.
The historical rank and industry rank for Pulsenmore's Days Payable or its related term are showing as below:
PLSM'
s Days Payable Range Over the Past 10 Years
Min: 124.53 Med: 218.47 Max: 493.62
Current: 124.53
During the past 7 years, Pulsenmore's highest Days Payable was 493.62. The lowest was 124.53. And the median was 218.47.
PLSM's Days Payable is ranked better than 72.49% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs PLSM: 124.53
Pulsenmore's Days Payable
declined
from Dec. 2024 (101.65) to Dec. 2025 (99.24).
It may suggest that Pulsenmoreaccelerated paying its suppliers.
Pulsenmore Days Payable Related Terms
Pulsenmore Days Payable Historical Data
* Premium members only.
The historical data trend for Pulsenmore's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Pulsenmore's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulsenmore Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulsenmore's Days Payable distribution charts can be found below:
* The bar in red indicates where Pulsenmore's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pulsenmore's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulsenmore (PLSM) has a Days Payable of 99.24 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pulsenmore and its competitors. This is 55% below median its historical median of 218.47. Over the past decade, Pulsenmore's Days Payable has ranged from 124.53 to 493.62. According to the industry distribution chart, Pulsenmore ranks #219 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 27.5%.
Is Pulsenmore's Days Payable too high?
Pulsenmore's current Days Payable of 99.24 is 55% below median its 10-year median of 218.47. Over the past 10 years, this metric has ranged from a low of 124.53 to a high of 493.62. The Medical Devices & Instruments industry median Days Payable is 67.97. Pulsenmore's value of 99.24 is 46% above this industry median. Based on the distribution chart, Pulsenmore ranks #219 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pulsenmore has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pulsenmore's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Pulsenmore ranks #219 out of 796 companies for Days Payable. This puts Pulsenmore in the upper half of its industry. The industry median Days Payable is 67.97. Pulsenmore's value of 99.24 is 46% above this benchmark. Historically, Pulsenmore's own Days Payable has ranged from 124.53 to 493.62 over the past decade. While the company's 10-year median is 218.47 vs. the industry median of 67.97, Pulsenmore has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulsenmore's current Days Payable of 99.24 is 46% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pulsenmore and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulsenmore's current Days Payable is 99.24, which is 55% below median its own 10-year median of 218.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulsenmore stock overvalued right now?
Based on GuruFocus' analysis, Pulsenmore (PLSM) is currently considered Possible Value Trap. The stock's GF Value™ is $8.16, compared to a current price of $3.60 — trading 55.9% below its estimated fair value. The current Days Payable is 99.24, which is 55% below median its 10-year median of 218.47 and 46% above the Medical Devices & Instruments industry median of 67.97. Pulsenmore's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pulsenmore (PLSM), the current Days Payable is 99.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pulsenmore (PLSM) Overvalued in 2026?
Based on GuruFocus' analysis, Pulsenmore stock appears to be undervalued.
The current stock price of $3.60 is trading 55.9% below its estimated GF Value™ of $8.16.
GuruFocus considers Pulsenmore to be Possible Value Trap.
Key valuation signals for PLSM:
Days Payable: 99.24 (55% below median its 10-year median of 218.47)
GF Value™: $8.16 vs. price of $3.60 (55.9% below fair value)
Industry Position: 46% above the Medical Devices & Instruments median (#219 of 796)
No single metric tells the full story. See the PLSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
25GF Score
Get the complete analysis for PLSM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSM has been successfully added to your 
